Evidence map›Paper›PMID 42254046›Full record

ArticleJournal of cardiology cases2026

Left atrial dominant cardiac sarcoidosis presenting with supraventricular tachycardia and left atrial myocardial damage: A case report.

Ayaka Fujita, Takahiro Sakamoto, Shinichi Kurashima, Yuki Irie, Kenji Moriuchi, Atsushi Okada, Masashi Amano, Makoto Amaki, Hideaki Kanzaki, Takeshi Kitai and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ayaka FujitaDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Takahiro SakamotoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Shinichi KurashimaDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yuki IrieDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kenji MoriuchiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Atsushi OkadaDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Masashi AmanoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Makoto AmakiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hideaki KanzakiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Takeshi KitaiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Chisato IzumiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 61-year-old woman presented to our hospital with palpitations and dyspnea persisting for several months. Electrocardiography revealed atrial tachycardia, and X-ray revealed bilateral hilar enlargement. Computed tomography (CT) was performed for suspected sarcoidosis of the respiratory system, which revealed hilar lymph node enlargement in the bilateral lungs. Learning objective: The main site of cardiac sarcoidosis involvement is the left ventricle, and cases in which inflammation is confined to the left atrium are rare. In left atrial dominant cardiac sarcoidosis, clinical manifestations are often limited to supraventricular tachycardia. Although immunosuppressive therapy controlled the arrhythmia, multimodality imaging revealed that left atrial structural damage persisted, even after inflammation had improved. These findings highlight the clinical importance of recognizing left atrial dominant cardiac sarcoidosis, as irreversible atrial damage may persist despite adequate treatment.

Indexed as

Atrial tachycardiaLeft atriumSarcoidosis

Identifiers

PMID42254046
PMCPMC13241998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.